DI GIULIO, ANNA MARIA
 Distribuzione geografica
Continente #
EU - Europa 16.483
NA - Nord America 7.996
AS - Asia 3.615
SA - Sud America 143
OC - Oceania 54
AF - Africa 29
Continente sconosciuto - Info sul continente non disponibili 8
Totale 28.328
Nazione #
GB - Regno Unito 8.223
US - Stati Uniti d'America 7.817
IT - Italia 2.271
DE - Germania 1.934
CN - Cina 1.812
SE - Svezia 1.429
TR - Turchia 491
UA - Ucraina 474
FR - Francia 467
IE - Irlanda 405
KR - Corea 399
IN - India 307
RU - Federazione Russa 307
FI - Finlandia 279
EU - Europa 251
NL - Olanda 227
VN - Vietnam 208
HK - Hong Kong 160
CA - Canada 157
BE - Belgio 147
DK - Danimarca 95
CO - Colombia 78
GR - Grecia 62
JP - Giappone 61
SG - Singapore 55
AU - Australia 47
ID - Indonesia 46
BR - Brasile 41
CH - Svizzera 32
PL - Polonia 28
ES - Italia 23
PT - Portogallo 19
MX - Messico 17
HU - Ungheria 15
IR - Iran 12
RO - Romania 12
TW - Taiwan 12
CL - Cile 10
CZ - Repubblica Ceca 10
CI - Costa d'Avorio 9
EG - Egitto 8
NZ - Nuova Zelanda 7
SA - Arabia Saudita 7
MY - Malesia 6
NO - Norvegia 5
TH - Thailandia 5
AR - Argentina 4
AT - Austria 4
PE - Perù 4
PH - Filippine 4
PK - Pakistan 4
SC - Seychelles 4
UZ - Uzbekistan 4
AL - Albania 3
BO - Bolivia 3
IL - Israele 3
LB - Libano 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CR - Costa Rica 2
HR - Croazia 2
IQ - Iraq 2
JO - Giordania 2
KW - Kuwait 2
LK - Sri Lanka 2
NG - Nigeria 2
SK - Slovacchia (Repubblica Slovacca) 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BW - Botswana 1
CU - Cuba 1
EC - Ecuador 1
EE - Estonia 1
GH - Ghana 1
LT - Lituania 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
MU - Mauritius 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
PY - Paraguay 1
SI - Slovenia 1
SV - El Salvador 1
VE - Venezuela 1
Totale 28.573
Città #
Southend 7.865
Chandler 1.110
Milan 852
Seattle 670
Princeton 510
Frankfurt am Main 494
Hanover 439
Wilmington 430
Dublin 396
Beijing 387
Ann Arbor 323
Jacksonville 298
Dearborn 295
Redmond 294
Fairfield 283
Mountain View 281
Houston 265
Ashburn 237
Nanjing 219
Woodbridge 213
Serra 207
Des Moines 186
Sakarya 185
Brooklyn 184
Bengaluru 146
Brussels 144
Dong Ket 140
Boardman 139
Jinan 137
Toronto 131
Hong Kong 129
Cambridge 128
Grafing 123
Shenyang 107
Andover 96
Medford 94
Bogotá 77
Phoenix 75
Nanchang 67
Helsinki 65
Hebei 63
Saint Petersburg 61
Somerville 59
New York 58
Redwood City 58
Shanghai 56
Tianjin 54
Berlin 53
Athens 52
Changsha 51
Seoul 47
Guangzhou 46
Bitonto 44
Ningbo 44
Rome 44
San Diego 43
Jiaxing 41
Turin 39
Hangzhou 37
Zhengzhou 37
Haikou 35
Falls Church 31
Lanzhou 27
Kiez 25
Istanbul 24
Kunming 24
Verona 24
Auburn Hills 23
Hefei 23
Taizhou 22
Los Angeles 21
Roxbury 21
Scranton 20
Fuzhou 19
Warsaw 17
Central District 16
Chengdu 16
Palermo 15
Tappahannock 15
Sydney 14
Bologna 13
London 13
Munich 13
Silver Spring 13
Tokyo 13
Coral Gables 12
Nürnberg 12
Perugia 12
Taiyuan 12
Torino 12
Chicago 11
Duncan 11
Paris 11
Wuhan 11
Costa Mesa 10
Foshan 10
Jamestown 10
Mumbai 10
Naples 10
Norwalk 10
Totale 20.069
Nome #
Farmacologia generale e speciale per lauree sanitarie 503
Fresh and frozen Lipogems-derived micro-fractured human adipose tissue generates mesenchymal stem cells with higher differentiation potential and in vivo repair efficacy 417
Anti-EGFR Antibody Efficiently and Specifically Inhibits Human TSC2-/- Smooth Muscle Cell Proliferation. Possible Treatment Options for TSC and LAM 370
HuR interacts with lincBRN1a and lincBRN1b during neuronal stem cells differentiation 365
New non-synthetic molecules are able to inhibit Apoptosis 334
G protein-mediated signal transduction is affected in primary biliary cirrhosis 260
Organizzazione e valutazione del tirocinio pratico nel Corso di Laurea in Fisioterapia 259
Adipose-Derived Stem Cells from Fat Tissue of Breast Cancer Microenvironment Present Altered Adipogenic Differentiation Capabilities 250
Exogenous adult post mortem neural precursors attenuate secondary degeneration, and promote myelin sparing and functional recovery following experimental spinal cord injury 249
The methylation of the TSC2 promoter underlies the abnormal growth of TSC2 angiomyolipoma-derived smooth muscle cells 243
Third trimester human amniotic fluid cells isolation and phenothypical characterizzation 243
Acute spinal cord injury persistently reduces R/G RNA editing of AMPA receptors 229
Up-regulation of focal adhesion kinase in non-small cell lung cancer 220
Phenotypical characterization of third trimester human amniotic fluid cells: a new reservoir of stem cells? 220
Degradation of insulin-like growth factor-I receptor occurs via ubiquitin-proteasome pathway in human lung cancer cells 210
Adult neural precursors isolated from post mortem brain yield mostly neurons : An erythropoietin-dependent process 210
Acrylate end-capped poly(ester-carbonate) and poly(ether-ester)s for polymer-on-multielectrode array devices : synthesis, photocuring, and biocompatibility 209
ERITROPOIETINA RICOMBINANTE UMANA ATTENUA LA DEGENERAZIONE SECONDARIA E PROMUOVE IL RECUPERO NEUROLOGICO NEL TRAUMA DEL MIDOLLO SPINALE SPERIMENTALE 208
Third trimester amniotic fluid cells with the capacity to develop neural phenotypes and with heterogeneity among sub-populations 208
Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma : epidermal growth factor is the required growth factor 206
Characterization of LAM/TSC cells isolated from patient chylous 204
Death resistant neural progenitors yield mostly neurons: an erythropoietin-dependent process 203
LAM/TSC cell migration to uterus in an experimental model of lymphangioleiomyomatosis. Regulation by anti-epidermal growth factor receptor antibody and rapamycin 199
Anti-EGFR antibody reduces lung nodules by inhibition of EGFR-pathway in a model of lymphangioleiomyomatosis 198
Farmacologia 197
Fresh and frozen micro-fractured human adipose tissue generates mesenchymal stem cells with higher differentiation potential and in vivo repair efficacy 194
Magnetic and fluorescence labelling for in vivo neural stem cell transplantation monitoring 189
PHENOTYPICAL CHARACTERIZATION OF THIRD TRIMESTER HUMAN AMNIOTIC FLUID CELLS WITH POTENTIAL FOR THERAPY IN NEURODEGENERATIVE DISORDERS 188
Development of a LAM model by using human TSC2-/- cells derived from a renal angiomyolipoma : A pharmacological evaluation 186
Death resistant neural stem cell regenerate neuronal tissue and promote functional recovery after transplantation in a spinal cord injury model 185
Early and late posts mortem neural stem cells grow and differentiate in vitro : a novel source for cellular therapy 184
A mouse LAM model by endonasal administration of human TSC2 deficient smooth muscle cells 184
Amelioration of neutrophil membrane function underlies granulocyte-colony stimulating factor action in glycogen storage disease 1B 183
Pathogenesis and pharmacological evaluation of human TSC2 smooth muscle cells. Possible treatment options for TSC and lymphangioleiomyomatosis 181
Expression of the anti-apoptotic protein survivin amd altered function of IGF-1 pathway in TSC2 brain tubers 181
Expression of surface and intracellular specific markers by human stem cells derived from Lipostem™-treated adipose tissue 180
Human smooth muscle TSC2-/- cells cause lymphangiogenesis-like lung destruction in nude mice. Pharmacological repair 179
3-Methoxytyramine and different neuroleptics: Dissociation from HVA and DOPAC 179
Erythropoietin as a Neuroprotective Molecule: An Overview of Its Therapeutic Potential in Neurodegenerative Diseases 177
Third trimester human amniotic fluid cells from caesarean births; a new tool for therapy in neurodegenerative disorders 176
Valutazione del tirocinio 174
A new class of adult neural stem cells migrate to the injured spinal cord and differentiate into cholinergic neurons 174
Isolation and characterization of a new class of adult neural precursors 174
Eryrhropoietin increase neuronal differentiation increase neuronal stem cells and death resistant neural stem cells 173
Erythropoietin : recent developments in the treatment of spinal cord injury 173
Master universitario di II livello "integrazione tra medicina tradizionale cinese e medicina occidentale" 171
Farmacologia 171
Un modello di linfangioleiomiomatosi con la somministrazione di cellule muscolari lisce umane TSC2-/- 171
Enhanced brain release of erythropoietin, cytokines and NO during carotid clamping 171
PATHOGENESIS AND PHARMACOLOGY OF ISOLATED HUMAN TSC2 SMOOTH MUSCLE CELLS. NOVEL THERAPEUTIC PERSPECTIVES 169
Role of HMG-CoA reductase inhibitors in controlling TSC2-/- ASM cell growth and proliferation 168
Spinal cord injury : a comparison of neural stem cell and embryonic stem cell treatments 166
Third trimester NG2-positive amniotic fluid cells are effective in improving repair in spinal cord injury 165
Development of a LAM model by using human TSC2 deficient smooth muscle cells derived from a renal angiomylipoma 163
Methylprednisolone neutralizes the beneficial effects of erythropoietin in experimental spinal cord injury 162
Molecular characterization of growth and survival of human TSC2 gene-deficient smooth muscle-like cells 162
Phenotype reversion of human TSC2-/- smooth muscle cells 161
Exogenous adult mouse post mortem neural promote functional recovery in a mouse model of Parkinson disease and differentiate in TH-positive neurons 161
Third trimester human amniotic fluid cells with potential for therapy in neurodegenerative disorders 160
A role for enhanced integrin and FAK expression in uremia-induced parathyroid hyperplasia 159
TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival 159
Promoter methylation of TSC2 gene is important for pathogenesis of TSC and LAM lesions 158
Survivin expression in tuberous sclerosis complex cells 158
Mitochondrial Metabolism as Target of the Neuroprotective Role of Erythropoietin in Parkinson’s Disease 158
Fate of autologous dermal stem cells transplanted into the spinal cord after traumatic injury (TSCI) 156
Anti-EGFR antibody efficiently and specifically inhibits human TSC2-/- smooth muscle cell proliferation. Possible treatment options for TSC and LAM 156
Inhibition of apoptosis-driven regression of hair bulb 156
Isolation and growth characterization of two types of human TSC2 gene-deficient cells 155
Pharmacological and biochemical characterization of isolated and in vitro grown human TSC2 gene-deficient smooth muscle-like cells 154
Human LAM/TSC cells efficiently cause lung nodule formation and alveolar destruction. Pharmacological counteraction by modulation of mTOR activity 154
An epigenetic event may underlies the TSC features in TSC2 ASM cells 152
Embryonic stem cells promote motor recovery and affect inflammatory cell infiltration in spinal cord injured mice 152
Farmacologia 152
Characteristics and properties of mesenchymal stem cells derived from micro-fragmented adipose tissue 152
The ribonucleic complex HuR-MALAT1 represses CD133 expression and suppresses epithelial-mesenchymal transition in breast cancer 152
Reversion of the phenotype of human TSC2-/- smooth muscle cells 151
LAM/TSC CELLS BEARING A TSC2 MUTATION SECRETE CHEMOKINES AND MATRIXMETHALLOPROTEINASES 151
ROSUVASTATIN ACTING AS A DEMETHYLATING AGENT AFFECTS PROLIFERATION OF TSC2-/meth ASM CELLS 150
Proliferation and invasiveness of human smooth muscle TSC2-/- : Effect of anti-EGFR and rapamycin 149
Single exposure to erythropoietin modulates Nerve Growth Factor expression in the spinal cord following traumatic injury : comparison with methylprednisolone 149
Neuroprotection, Recovery of Function and Endogenous Neurogenesis in Traumatic Spinal Cord Injury Following Transplantation of Activated Adipose Tissue 147
Magnetic Resonance Imaging of Stem Cell Transplantation in Injured Mouse Spinal Cord 146
Plasma amino acid concentrations throughout normal pregnancy and early stages of intrauterine growth restricted pregnancy 145
Characterization of human TSC2 cells derived from a TSC/LAM patient chylous effusion 145
Mechanisms of survival in TSC2-/- smooth muscle cells 144
Acute spinal cord injury reduces brain derived neurotrohic factor expression in rat hippocampus 144
MOTILITY AND INVASIVE PROPERTIES OF LAM/TSC CELLS FROM CHYLOUS OF A LAM/TSC PATIENT 144
From Neuronal Differentiation of iPSCs to 3D Neuro-Organoids : Modelling and Therapy of Neurodegenerative Diseases 144
Characterization of enkephalin-like material extracted from sympathetic ganglia 143
Exogenous adult post mortem neural precursors attenuate secondary degeneration, and promote myelin sparing and functional recovery following experimental spinal cord injury 142
Spinal cord injury and neural stem cells transplantation 140
Phenotype plasticity of mesenchymal stem cells from Lipostem™-derived human adipose tissue 140
Exogenous adult mouse post mortem neural promote functional recovery in a mouse model of Parkinson disease and differentiate in TH-positive neurons 138
Matrix methalloproteinase 2 and 7 are new targets in LAM and TSC-related disorders 137
Counteracting neuroinflammation in experimental Parkinson's disease favors recovery of function : effects of Er-NPCs administration 137
Pharmacological reversion of the phenotype of human TSC2-/- smooth muscle cells 136
Changes in specific activity of dopamine metabolites as evidence of a multiple compartmentation of dopamine in striatal neurons 134
Third trimester amniotic fluid cells improve motor recovery in a mouse model of Spinal Cord Injury 133
Inhibition of apoptosis-driven regression of hair bulb 132
Development of a cutaneous mouse model of TSC and LAM by injection of human tuberin-deficient cells : effects of chromatin remodelling agents 132
Totale 18.385
Categoria #
all - tutte 51.903
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.903


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.740 0 0 0 0 0 437 252 84 248 181 272 266
2019/20204.252 686 248 157 316 308 375 496 244 583 469 202 168
2020/20213.617 200 208 328 124 278 211 204 155 604 198 814 293
2021/20223.485 434 140 166 151 229 192 269 176 425 397 254 652
2022/20233.687 421 423 307 487 416 716 67 219 376 43 133 79
2023/20241.494 132 167 194 231 737 33 0 0 0 0 0 0
Totale 30.217